Establishment of the 1st WHO International Standard for anti-EV71 serum (Human). (May 2018)

• Record Type: Journal Article
• Authors: Cooper, Gillian; Mao, Qunying; Crawt, Laura; Wang, Yiping; Dougall, Thomas; Rigsby, Peter; Liang, Zhenglun; Xu, Miao; Minor, Philip; Wang, Junzhi; Martin, Javier
• Is Part Of: Biologicals. Volume 53(2018)
• Page Start: 39
• Page End: 50
• Publication Date: 2018-05
• Subjects: Enterovirus A71 -- International standard -- Neutralizing antibody -- Collaborative study -- Potency; Biological products -- Standards -- Periodicals; Biological Products -- Periodicals; Biological Products -- standards -- Periodicals; Produits biologiques -- Normes -- Périodiques; Biological products -- Standards; Periodicals; 615.37
• DOI: 10.1016/j.biologicals.2018.03.001
• Languages: English
• ISSNs: 1045-1056

Abstract

Abstract: Enterovirus A71 (EV71) is the major causative agent of severe and fatal hand, foot and mouth disease. There is plenty of evidence that EV71 has circulated widely in the Western Pacific Region for the last twenty years. Vaccines against EV71 are already available or under development. A collaborative study to establish the 1st WHO International Standard for anti-EV71 serum (Human) was conducted to ensure that methods used to measure the serum neutralizing activity or antibody levels against EV71 are accurate, sensitive and reproducible. Two candidate samples as well as a third candidate reference containing low anti-EV71 antibody titre were produced from plasma samples donated by healthy individuals. All three serum samples exhibited good levels of neutralizing antibodies against a wide range of EV71 strains of various genotypes. The study showed that between laboratory variations in neutralization titres were significantly reduced when values were expressed relative to those of either of the two candidate sera. Sample 14/140 was established as the WHO 1st International Standard for anti-EV71 serum (human), 14/138 as its potential replacement and 13/238 as a WHO Reference Reagent, with assigned unitage of 1, 000, 1090 and 300 International Units (IU) of anti-EV71 neutralizing antibodies per ampoule, respectively.